{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:51Z","timestamp":1790937111707,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"a UCL Wellcome Trust PhD Programme for Clinicians fellowship"},{"DOI":"10.13039\/501100001713","name":"European & Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014013","name":"UKRI;","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Department of Science and Technology"},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Drug regimens that include intensified antibiotics alongside effective anti-inflammatory therapies may improve outcomes in tuberculous meningitis (TBM). Safety data on their use in combination and in the context of human immunodeficiency virus (HIV) are needed to inform clinical trial design.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a phase 2, open-label, parallel-design, randomized, controlled trial to assess the safety of high-dose rifampicin, linezolid, and high-dose aspirin in HIV-associated TBM. Participants were randomized (1.4:1:1) to 3 treatment arms (1, standard of care [SOC]; 2, SOC + additional rifampicin [up to 35 mg\/kg\/d] + linezolid 1200 mg\/d reducing after 28 days to 600 mg\/d; 3, as per arm 2 + aspirin 1000 mg\/d) for 56 days, when the primary outcome of adverse events of special interest (AESI) or death was assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 52 participants with HIV-associated TBM were randomized; 59% had mild disease (British Medical Research Council (MRC) grade 1) vs 39% (grade 2) vs 2% (grade 3). AESI or death occurred in 10 of 16 (63%; arm 3) vs 4 of 14 (29%; arm 2) vs 6 of 20 (30%; arm 1; P = .083). The cumulative proportion of AESI or death (Kaplan\u2013Meier) demonstrated worse outcomes in arm 3 vs arm 1 (P = .04); however, only 1 event in arm 3 was attributable to aspirin and was mild. There was no difference in efficacy (modified Rankin scale) between arms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High-dose rifampicin and adjunctive linezolid can safely be added to the standard of care in HIV-associated TBM. Larger studies are required to determine whether potential toxicity associated with these interventions, particularly high-dose aspirin, is outweighed by mortality or morbidity benefit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trials Registration<\/jats:title><jats:p>NCT03927313.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciac932","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T04:03:21Z","timestamp":1670558601000},"page":"1412-1422","source":"Crossref","is-referenced-by-count":47,"title":["A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus\u2013Associated Tuberculous Meningitis: The LASER-TBM Trial"],"prefix":"10.1093","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-5094","authenticated-orcid":false,"given":"Angharad G","family":"Davis","sequence":"first","affiliation":[{"name":"Francis Crick Institute , London , United Kingdom"},{"name":"Faculty of Life Sciences, University College London , London , United Kingdom"},{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"},{"name":"Department of Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari","family":"Stek","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"},{"name":"Department of Infectious Diseases, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mpumi","family":"Maxebengula","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Jason Liang","sequence":"additional","affiliation":[{"name":"Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephani","family":"Stegmann","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Koekemoer","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Jackson","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakub","family":"Kadernani","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marise","family":"Bremer","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Daroowala","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"},{"name":"Department of Infectious Diseases, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saalikha","family":"Aziz","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Goliath","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Lai Sai","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandi","family":"Sihoyiya","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-079X","authenticated-orcid":false,"given":"Paolo","family":"Denti","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P J","family":"Lai","sequence":"additional","affiliation":[{"name":"Francis Crick Institute , London , United Kingdom"},{"name":"Department of Infectious Diseases, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Crede","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mitchells Plain Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Naude","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mitchells Plain Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Szymanski","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mitchells Plain Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakoob","family":"Vallie","sequence":"additional","affiliation":[{"name":"Department of Medicine, New Somerset Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail Abbas","family":"Banderker","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mitchells Plain Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed S","family":"Moosa","sequence":"additional","affiliation":[{"name":"Department of Medicine, New Somerset Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Raubenheimer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Candy","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Radiology, University of Cape Town, Groote Schuur Hospital , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Offiah","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Imaging Department, Royal London Hospital, Barts Health NHS Trust , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda","family":"Wahl","sequence":"additional","affiliation":[{"name":"Department of Medicine, Walter Sisulu University , Mthatha , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isak","family":"Vorster","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Radiology, University of Cape Town, Groote Schuur Hospital , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-6606","authenticated-orcid":false,"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"},{"name":"Division of Clinical Pharmacology, Department of Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Black","sequence":"additional","affiliation":[{"name":"Department of Medicine, Walter Sisulu University , Mthatha , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"},{"name":"Department of Medicine, University of Cape Town , Observatory , Republic of South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Francis Crick Institute , London , United Kingdom"},{"name":"Faculty of Life Sciences, University College London , London , United Kingdom"},{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town , Observatory , Republic of South Africa"},{"name":"Department of Medicine, University of Cape Town , Observatory , Republic of South Africa"},{"name":"Department of Infectious Diseases, Imperial College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"e20077","DOI":"10.1371\/journal.pone.0020077","article-title":"Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting","volume":"6","author":"Marais","year":"2011","journal-title":"PLoS One"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jinf.2009.07.012","article-title":"Tuberculous cerebrovascular disease: a review","volume":"59","author":"Lammie","year":"2009","journal-title":"J Infect"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eplepsyres.2018.10.005","article-title":"Seizures in tuberculous meningitis","volume":"148","author":"Misra","year":"2018","journal-title":"Epilepsy Res"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cid\/ciy020","article-title":"Spinal tuberculosis: clinicoradiological findings in 274 patients","volume":"67","author":"Marais","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"178","DOI":"10.12688\/wellcomeopenres.15516.1","article-title":"Neurocognitive and functional impairment in adult and paediatric tuberculous meningitis","volume":"4","author":"Davis","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tube.2010.07.002","article-title":"Cerebrospinal fluid concentrations of antituberculosis agents in adults and children","volume":"90","author":"Donald","year":"2010","journal-title":"Tuberculosis"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1507062","article-title":"Intensified antituberculosis therapy in adults with tuberculous meningitis","volume":"374","author":"Heemskerk","year":"2016","journal-title":"N Engl J Med"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/cid\/ciab162","article-title":"High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly human immunodeficiency virus (HIV)-positive Ugandan adults: a phase II open-label randomized controlled trial","volume":"73","author":"Cresswell","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023041720292736200_","author":"World Health Organization","year":"2019."},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/INF.0000000000001114","article-title":"Linezolid is associated with improved early outcomes of childhood tuberculous meningitis","volume":"35","author":"Li","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1128\/AAC.02784-14","article-title":"Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis","volume":"58","author":"Sun","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041720292736200_","first-page":"603","article-title":"Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis","volume":"7","author":"Zhang","year":"2015","journal-title":"J Thorac Dis"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/jac\/dkac019","article-title":"Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study","volume":"77","author":"Wasserman","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.mcna.2017.03.004","article-title":"Aspirin for primary prevention","volume":"101","author":"Richman","year":"2017","journal-title":"Med Clin North Am"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1734-1140(10)70308-X","article-title":"Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology","volume":"62","author":"Botting","year":"2010","journal-title":"Pharmacol Rep"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.110.223883","article-title":"Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins","volume":"107","author":"Spite","year":"2010","journal-title":"Circ Res"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"e33478","DOI":"10.7554\/eLife.33478","article-title":"A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults","volume":"7","author":"Mai","year":"2018","journal-title":"Elife"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/0883073811398132","article-title":"The role of aspirin in childhood tuberculous meningitis","volume":"26","author":"Schoeman","year":"2011","journal-title":"J Child Neurol"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.03.025","article-title":"Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial","volume":"293","author":"Misra","year":"2010","journal-title":"J Neurol Sci"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"136","DOI":"10.12688\/wellcomeopenres.16783.1","article-title":"Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]","volume":"6","author":"Davis","year":"2021","journal-title":"Wellcome Open Res"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","article-title":"Tuberculous meningitis: a uniform case definition for use in clinical research","volume":"10","author":"Marais","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2023041720292736200_","year":"2014"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"e0014021","DOI":"10.1128\/AAC.00140-21","article-title":"Plasma pharmacokinetics of high-dose oral vs intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial","volume":"65","author":"Wasserman","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"2023041720292736200_","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/598988","article-title":"Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series","volume":"48","author":"Pepper","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac932\/48843461\/ciac932.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/8\/1412\/50001345\/ciac932.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/8\/1412\/50001345\/ciac932.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T17:48:35Z","timestamp":1701539315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/8\/1412\/6884164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2023,4,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac932","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,15]]},"published":{"date-parts":[[2022,12,9]]}}}